AdaptHealth (AHCO) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.16
- EPS estimate
- $0.17
- EPS surprise
- −5.15%
- Revenue surprise
- −12.57%
- Revenue
- $740.3M
- Revenue estimate
- $846.8M
- Reported
- Aug 4, 2026
AdaptHealth reported Q2 2026 results on August 4, 2026. Earnings per share were $0.16, short of the $0.17 estimate by 5.15%. Revenue of $740.3 million came in 12.57% below the $846.8 million consensus. Compared with Q2 2025, EPS fell about 27% from $0.22 and revenue fell about 7.5% from $800.4 million.
The longer record shows earnings peaking in 2023. Annual EPS rose from $0.65 in 2022 to $1.26 in 2023, then eased to $0.96 in 2024 and $0.72 in 2025. Annual revenue held near $3.2 billion from 2023 to 2025. The first half of 2026 adds up to $0.10 per share, against $0.25 a year earlier, after a loss of $0.06 per share in Q1 2026, the only loss in the table. Q4 2023 holds the highs here at $0.56 per share and $858.2 million in revenue. Q2 2026 revenue was the lowest since Q2 2022. Over the last 20 quarters, AdaptHealth's EPS came in above the estimate 8 times, while revenue beat the consensus 15 times.
AdaptHealth reported Q3 between November 4 and November 8 in each of the past five years. That points to early November 2026 for the next report.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 4, 2026 | $0.17 | $0.16 | −5.15% | $740.3M | SEC |
| Q1 2026 | May 5, 2026 | $0.01 | −$0.06 | −545.60% | $819.8M | SEC |
| Q4 2025 | Feb 24, 2026 | $0.35 | $0.23 | −35.21% | $846.3M | SEC |
| Q3 2025 | Nov 4, 2025 | $0.24 | $0.24 | −1.66% | $820.3M | SEC |
| Q2 2025 | Aug 5, 2025 | $0.16 | $0.22 | +38.26% | $800.4M | SEC |
| Q1 2025 | May 6, 2025 | $0.05 | $0.03 | −42.16% | $777.9M | SEC |
| Q4 2024 | Feb 25, 2025 | $0.28 | $0.43 | +51.53% | $856.6M | SEC |
| Q3 2024 | Nov 5, 2024 | $0.19 | $0.22 | +17.20% | $805.9M | SEC |
| Q2 2024 | Aug 6, 2024 | $0.19 | $0.22 | +16.15% | $806.0M | SEC |
| Q1 2024 | May 7, 2024 | $0.05 | $0.09 | +96.22% | $792.5M | SEC |
| Q4 2023 | Feb 27, 2024 | $0.19 | $0.56 | +188.68% | $858.2M | SEC |
| Q3 2023 | Nov 7, 2023 | $0.20 | $0.42 | +110.17% | $804.0M | SEC |
| Q2 2023 | Aug 8, 2023 | $0.13 | $0.23 | +73.02% | $793.3M | SEC |
| Q1 2023 | May 9, 2023 | $0.10 | $0.05 | −46.96% | $744.6M | SEC |
| Q4 2022 | Feb 27, 2023 | $0.31 | $0.05 | −82.51% | $780.3M | SEC |
| Q3 2022 | Nov 8, 2022 | $0.31 | $0.22 | −28.25% | $756.5M | — |
| Q2 2022 | Aug 9, 2022 | $0.29 | $0.18 | −38.02% | $727.6M | — |
| Q1 2022 | May 10, 2022 | $0.21 | $0.20 | −1.02% | $706.2M | — |
| Q4 2021 | Feb 24, 2022 | $0.38 | $0.29 | −23.74% | $702.1M | — |
| Q3 2021 | Nov 4, 2021 | $0.35 | $0.34 | −1.22% | $653.3M | — |
Quarterly revenue
Frequently asked questions
When did AdaptHealth (AHCO) last report earnings?
AdaptHealth last reported on Aug 4, 2026, covering fiscal Q2 2026.
Did AHCO beat earnings estimates?
No. AdaptHealth reported EPS of $0.16 for Q2 2026 against a $0.17 estimate — a 5.15% miss.
How much revenue did AHCO report last quarter?
AdaptHealth reported $740.3M in revenue for Q2 2026, against a consensus estimate of $846.8M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.